Gladstone welcomes inquiries from journalists. Our media-relations staff is on hand to provide local, regional, national, and international journalists with accurate information about Gladstone’s research and our investigators’ areas of expertise. We are available to arrange interviews with Gladstone scientists and assist in developing story ideas.
As coronavirus concerns grow, Gladstone's virology experts are here to answer your questions, offer insight, provide context, and discuss the impacts of the outbreak on public health.
Gladstone virology experts are available for media interviews.
At Gladstone, we believe that basic science will be key for identifying potential drug targets and creating an effective vaccine. Both are sorely needed. Antivirals that can control coronavirus growth could have a huge impact not only on disease outcome but also on virus transmission from one person to another.
Associate Director, Communications
Direct line: 415.734.5000
Vice President of Communications
Direct line: 415.734.2019
1 - 15 of 140 Results
Gladstone scientists engineer living biosensors to track the genetic activity of cellsNews Release Research (Publication) Data Science and Biotechnology Shipman Lab
Researchers used virus-like particles to identify which mutations of the Omicron SARS-CoV-2 virus make it more effective at infecting cells and escaping antibodiesNews Release Research (Publication) COVID-19 Virology Doudna Lab Ott Lab
The new study paves the way toward more effective cancer immunotherapiesNews Release Cancer Genomic Immunology Marson Lab
Scientists from Gladstone and UC San Francisco systematically tested ways to improve the efficacy of therapeutic cells targeting cancerNews Release Research (Publication) Cancer Genomic Immunology
Researchers have discovered why immune treatments for allergies and asthma might not be as effective in obese mice and humansNews Release Research (Publication) Genomic Immunology Marson Lab